PUCCETTI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 5.366
EU - Europa 5.267
AS - Asia 926
SA - Sud America 13
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 11.593
Nazione #
US - Stati Uniti d'America 5.343
GB - Regno Unito 1.388
IE - Irlanda 930
CN - Cina 676
IT - Italia 664
UA - Ucraina 558
SE - Svezia 541
RU - Federazione Russa 359
FR - Francia 339
DE - Germania 237
SG - Singapore 170
FI - Finlandia 148
CA - Canada 22
BE - Belgio 18
TR - Turchia 18
CZ - Repubblica Ceca 15
NL - Olanda 14
ES - Italia 11
JP - Giappone 10
VN - Vietnam 10
IN - India 8
CH - Svizzera 6
RO - Romania 6
BR - Brasile 5
EU - Europa 5
ZA - Sudafrica 5
AU - Australia 4
MY - Malesia 4
CI - Costa d'Avorio 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AT - Austria 2
AZ - Azerbaigian 2
CL - Cile 2
GR - Grecia 2
ID - Indonesia 2
MT - Malta 2
NO - Norvegia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
HK - Hong Kong 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 11.593
Città #
Southend 1.267
Dublin 930
Fairfield 839
Chandler 454
Jacksonville 445
Ashburn 426
Woodbridge 389
Wilmington 336
Houston 312
Seattle 301
Cambridge 248
Ann Arbor 217
Princeton 185
Nanjing 169
Beijing 152
Singapore 129
Siena 126
New York 111
San Mateo 72
Shanghai 60
Boardman 59
Helsinki 59
San Diego 56
Milan 51
Florence 42
Nanchang 41
Hebei 35
Moscow 33
Rome 26
Changsha 25
Jiaxing 25
Shenyang 25
Dearborn 24
Lancaster 24
Menlo Park 22
Tianjin 19
Brussels 17
Kunming 17
Hangzhou 16
Munich 16
Jinan 14
San Francisco 14
Toronto 14
Brno 12
Düsseldorf 12
London 12
Ningbo 12
Norwalk 12
Grosseto 11
Izmir 11
Málaga 11
Los Angeles 10
Philadelphia 9
Taizhou 9
Torino 9
Washington 9
Chicago 8
Dong Ket 8
Redwood City 8
Cecina 7
Columbus 7
Edinburgh 7
Naples 7
Tokyo 7
Paris 6
Santa Clara 6
Venezia 6
Falls Church 5
Fremont 5
Guangzhou 5
Kilburn 5
Lanzhou 5
Parma 5
Signa 5
Turin 5
Amsterdam 4
Auburn Hills 4
Aversa 4
Bari 4
Bologna 4
Cascina 4
Chieti 4
Fuzhou 4
Lucca 4
Pescara 4
Pozzallo 4
Sacramento 4
Trieste 4
Vienna 4
Zhengzhou 4
Abidjan 3
Acerra 3
Arezzo 3
Bishkek 3
Buscate 3
Campi Bisenzio 3
Changchun 3
Chirignago 3
Colombo 3
Dallas 3
Totale 8.188
Nome #
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 285
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 255
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 209
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 205
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 204
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome 199
Quantitative evaluation of microvessels in Behcet's disease 199
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 198
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 197
Takayasu's arteritis: case report of a patient with recurrent subclavian steal syndrome 170
Cytokines in acute coronary syndromes 159
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 156
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. 154
Long-Term use of ticagrelor in patients with prior myocardial infarction 153
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 149
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients 149
Heart failure and chronic kidney disease in a registry of internal medicine wards 146
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 143
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 143
Cardiac papillary fibroelastoma: An unusual source of cerebral embolism solved with local fibrinolysis 143
Potenziale endogeno di trombina e parametri di screening della coagulazione. 143
Cardiac dysautonomia and arterial distensibility in essential hypertensives 142
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 138
Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment 136
Effect of two single oral doses of mesoglycan on the coagulative and fibrinolytic system in human. A pharmacodynamic study [Azione di due dosi orali singole di mesoglicano sul sistema coagulativo-fibrinolitico dell'uomo. Studio farmacodinamico] 134
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects 134
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 133
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 133
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 131
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure 128
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 127
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 127
In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study 126
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study 125
Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion 125
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype 125
Protective effects of novel metal-nonoates on the cellular components of the vascular system 124
Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function 123
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study 123
Pharmacogenetics of statins therapy 123
Platelet hyperactivity after statin treatment discontinuation 123
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly 121
L’apoptosi linfocitaria nell’infarto miocardico acuto senza sopraelevazione del tratto ST 120
Time-dependent effect of statins on platelet function in hypercholesterolaemia 118
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments 117
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects 117
Genetic influence in statin intolerance 117
Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study 116
Transmitral and pulmonary venous flow study in elite male runners and young adults 115
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study 114
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 113
Different mechanisms of fibrinolysis impairment among dyslipidemic subjects 112
Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition 112
Structural and functional abnormality of systemic microvessels in cardiac syndrome X 111
Role of genetic factors in statins side-effects 111
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 107
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 107
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 106
Chronic urticaria and blastocystis hominis infection. A case report 105
Safety of long-term simvastatin discontinuation 105
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards 105
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes? 105
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia 104
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects 104
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 103
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes 102
null 101
Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine 100
Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin 99
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 99
Different effect induced by treatment with statins on monocyte tissue factor expression in hypercholesterolemic subjects 96
T cell activation and enhanced apoptosis in non-ST elevation myocardi infarction 95
Microvascular assessment in Behcet disease: videocapillaroscopic study. 95
Dyslipidemias and fibrinolysis. 94
Effetto dell' acido acetilsalicilico e della pentossifillina sulle variazioni diurne dell' attività anticoagulante dell' eparina non frazionata somministrata per infusione continua endovenosa nell' uomo 92
Circulating esRAGE is Associated with a Pro-Inflammatory/Pro-Atherothrombotic Profile in Familial Combined Hyperlipidemia Patients with Non-alcoholic Fatty Liver Disease 90
Complement activation in hypercholesterolemia 89
Evidences of new risk factors for retinal vein thrombosis 89
Central Retinal Vein Occlusion and Prothrombotic Factors 87
Le sfide dell’integrazione in Toscana: una riflessione dall’Osservatorio sociale regionale 83
Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling 80
Refractory Takayasu arteritis successfully treated with infliximab 79
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects 79
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 79
Diatolic filling in hypertrophied hearts of elite runners: an echo-doppler study 77
Mechanism for antiplatelet action of statins 73
Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation. In vitro effect of cerivastatin 71
The role of 3D and speckle tracking echocardiography in cardiac amyloidosis: a case report 71
MEDICAL TREATMENT OF CRVO 66
Relationship between serum complement and different lipid disorders 62
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 62
PHARMACODYNAMIC EFFECTS OF SULODEXIDE ON PROFYBRINOLYTIC AND HAEMORRHEOLOGICAL PATTERNS 58
Il potenziale endogeno di trombina nel laboratorio clinico. 56
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 54
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 51
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 44
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 41
Report of two cases of subconjunctival haemorrhage as first sign of post‐pregnancy acquired haemophilia a (AHA) 39
New generation analysis of thrombin generation in retinal vein thrombosis 35
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 33
Totale 11.625
Categoria #
all - tutte 37.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.467 0 0 0 0 142 165 200 319 217 230 59 135
2020/20211.512 79 169 62 158 49 169 75 223 190 121 135 82
2021/20221.299 102 158 88 160 70 22 63 36 58 126 118 298
2022/20231.782 109 142 267 227 167 360 33 148 180 28 93 28
2023/20241.493 55 35 122 71 53 451 485 34 16 38 41 92
2024/2025654 63 138 280 143 30 0 0 0 0 0 0 0
Totale 11.689